Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

8.22
+0.02000.24%
Volume:1.33M
Turnover:11.02M
Market Cap:1.13B
PE:-2.15
High:8.51
Open:8.26
Low:8.11
Close:8.20
Loading ...

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
27 Feb

Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference

Business Wire
·
20 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Irhythm Technologies (IRTC), Vir Biotechnology (VIR) and Biogen (BIIB)

TIPRANKS
·
13 Feb

Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025

Business Wire
·
13 Feb

Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Jan

Why Vir Biotechnology, Inc. (VIR) Is Skyrocketing Now

Insider Monkey
·
24 Jan

Bank of America Securities Sticks to Their Hold Rating for Vir Biotechnology (VIR)

TIPRANKS
·
15 Jan

Analysts Offer Insights on Healthcare Companies: Vir Biotechnology (VIR), Edgewise Therapeutics (EWTX) and Avadel Pharmaceuticals (AVDL)

TIPRANKS
·
13 Jan

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Vir Biotechnology (VIR)

TIPRANKS
·
12 Jan

Weekly Winners|FUBO Soars 255%; VIR Surges by 61%; CEG and WBA Jump Over 20%

Tiger Newspress
·
12 Jan

Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why

Benzinga
·
11 Jan

Vir Biotechnology Inc : Morgan Stanley Raises to Overweight From Equal-Weight

THOMSON REUTERS
·
10 Jan

Stock Track | Vir Biotechnology Soars 5.83% as Cancer Drugs Show Promise

Stock Track
·
10 Jan

BUZZ-Morgan Stanley upgrades Vir Biotechnology on cancer drugs trial data

Reuters
·
10 Jan

Vir Biotechnology Price Target Maintained With a $110.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Jan

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks
·
10 Jan